Additional adverse reactions were observed in patients treated with aprepitant (# mg) for postoperative nausea and vomiting and a greater incidence than with ondansetron: abdominal pain upper, bowel sounds abnormal, dysarthria, dyspnoea, hypoaesthesia, insomnia, miosis, nausea, sensory disturbance, stomach discomfort, visual acuity reduced, wheezing
Celkovo, v rámci oboch štúdií, mali pacienti, ktorí užívali IntronA plus ribavirín nižšiu pravdepodobnosť odpovede než pacienti, ktorí užívali pegylovaný interferón alfa-#b s ribavirínomEMEA0.3 EMEA0.3